Clinical Trial Update: Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing olmesartan, amlodipine, and hydrochlorothiazide in essential hypertension completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
• Olmesartan (olmesartan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2012-04-06